Start an analysis for JPM
JPMorgan Chase & Co.
Stock · NYSEProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $50.0bn | 30-Sep-26 | 10-Q filed 03-Nov-26 |
| Remaining authorization | $48.9bn | 30-Sep-26 | 10-Q filed 03-Nov-26 |
| Program expiry | n/a | — | |
| Repurchased last quarter | $1.1bn | 30-Sep-26 | 10-Q filed 03-Nov-26 |
| Has used an ASR | No | — |
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 24-Jun-26 | $50.0bn | $48.9bn | n/a | On June 24, 2026, the Firm announced that its Board of Directors had authorized a new $50 billion common share repurchase program, effective July 1, 2026.10-Q filed 03-Nov-26 |
Open-market repurchases
- Jul ’26
- Aug ’26
- Sep ’26
| Month ended | Shares | Avg price | ≈ Value | Source |
|---|---|---|---|---|
| 30-Sep-26 | 0 | — | $0 | 10-Q filed 03-Nov-26 |
| 31-Aug-26 | 0 | — | $0 | 10-Q filed 03-Nov-26 |
| 31-Jul-26 | 3,089,479 | $342.33 | $1.1bn | 10-Q filed 03-Nov-26 |